乳腺癌术后再发卵巢癌的预防与诊治

被引:9
作者
李倩
王纯雁
机构
[1] 中国医科大学肿瘤医院辽宁省肿瘤医院妇科
关键词
乳腺癌; 卵巢癌; 预防;
D O I
10.19538/j.fk2017040112
中图分类号
R737.31 [卵巢肿瘤]; R737.9 [乳腺肿瘤];
学科分类号
100214 [肿瘤学];
摘要
乳腺癌是女性最常见的恶性肿瘤,如有未婚未育史、家族遗传史、三阴性乳腺癌、术后口服选择性雌激素拮抗剂及BRCA1/BRCA2基因突变者,应特别警惕乳腺癌术后再发卵巢癌的可能。通过基因检测、临床筛查及降风险输卵管卵巢切除术(risk-reducing salpingo-oophorectomy,RRSO)的方法,可以有效预防乳腺癌术后再发卵巢癌。而对于乳腺癌术后已经发现卵巢癌者,应尽早接受治疗。乳腺癌与卵巢癌的发病间隔≥5年的患者所占比例最高,提示获得长期生存的乳腺癌患者也要警惕卵巢癌的发生。
引用
收藏
页码:371 / 376
页数:6
相关论文
共 11 条
[1]
乳腺癌术后患者附件区肿块的诊断和治疗 [J].
康华峰 ;
代志军 ;
马小斌 ;
包兴 ;
林帅 ;
刘小旭 ;
王西京 .
中华临床医师杂志(电子版), 2013, 7 (08) :3320-3323
[2]
Cancer Statistics, 2016 [J].
Siegel, Rebecca L. ;
Miller, Kimberly D. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (01) :7-30
[3]
Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3; CEA; and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer.[J].S?ren Kristiansen;Lars M?nster J?rgensen;Morten H?gh Hansen;Dorte Nielsen;Gy?rgy S?létormos;Vivian Barak.BioMed Research International.2015,
[4]
High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation [J].
Gorodnova, Tatiana V. ;
Sokolenko, Anna P. ;
Ivantsov, Alexandr O. ;
Iyevleva, Aglaya G. ;
Suspitsin, Evgeny N. ;
Aleksakhina, Svetlana N. ;
Yanus, Grigory A. ;
Togo, Alexandr V. ;
Maximov, Sergey Ya. ;
Imyanitov, Evgeny N. .
CANCER LETTERS, 2015, 369 (02) :363-367
[5]
Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes [J].
Bassuk, Shari S. ;
Manson, JoAnn E. .
ANNALS OF EPIDEMIOLOGY, 2015, 25 (03) :193-200
[6]
BRCA1/2 mutations and expression: Response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancer [J].
Dann, Rebecca Byler ;
DeLoia, Julie A. ;
Timms, Kirsten M. ;
Zorn, Kristin K. ;
Potter, Jennifer ;
Flake, Darl D., II ;
Lanchbury, Jerry S. ;
Krivak, Thomas C. .
GYNECOLOGIC ONCOLOGY, 2012, 125 (03) :677-682
[7]
Hormone prevention strategies for breast, endometrial and ovarian cancers [J].
Rice, Laurel W. .
GYNECOLOGIC ONCOLOGY, 2010, 118 (02) :202-207
[8]
Secondary Ovarian Malignancies Frequency, Origin, and Characteristics [J].
de Waal, Yvonne R. P. ;
Thomas, Chris M. G. ;
Oei, Angele L. M. ;
Sweep, Fred C. G. J. ;
Massuger, Leon F. A. G. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) :1160-1165
[9]
Combining a symptoms index with CA 125 to improve detection of ovarian cancer [J].
Andersen, M. Robyn ;
Goff, Barbara A. ;
Lowe, Kimberly A. ;
Scholler, Nathalie ;
Bergan, Lindsay ;
Dresher, Charles W. ;
Paley, Pamela ;
Urban, Nicole .
CANCER, 2008, 113 (03) :484-489
[10]
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations:: a case-control study [J].
McLaughlin, John R. ;
Risch, Harvey A. ;
Lubinski, Jan ;
Moller, Pal ;
Ghadirian, Parviz ;
Lynch, Henry ;
Karlan, Beth ;
Fishman, David ;
Rosen, Barry ;
Neuhausen, Susan L. ;
Offit, Kenneth ;
Kauff, Noah ;
Domchek, Susan ;
Tung, Nadine ;
Friedman, Eitan ;
Foulkes, William ;
Sun, Ping ;
Narod, Steven A. .
LANCET ONCOLOGY, 2007, 8 (01) :26-34